Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-17

Clinical Trial Update: Botulinum Toxins Intralesional Injection for Scar Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for intralesional botulinum toxin injections to treat scar pain in patients with scar keloid and hypertrophic scar.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Kaohsiung Medical University | Conditions: Scar Keloid, Hypertrophic Scar | Phase 4 | Status: UNKNOWN